Source Natural Foods & Herbal Supplements Ltd
Incorporated in 1998, Source Natural Foods and Herbal Supplements Ltd deals in ayurvedic products and green energy segment.[1]
- Market Cap ₹ 71.6 Cr.
- Current Price ₹ 111
- High / Low ₹ 170 / 96.6
- Stock P/E 21.1
- Book Value ₹ 40.0
- Dividend Yield 0.00 %
- ROCE 17.6 %
- ROE 14.1 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.7% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.54 | 10.93 | 15.94 | 10.84 | 12.81 | 13.59 | 24.88 | 21.53 | 19.79 | 27.30 | 44.92 | 70.38 | |
| 5.83 | 9.97 | 14.12 | 9.43 | 11.22 | 11.20 | 20.71 | 17.68 | 16.18 | 22.83 | 39.78 | 64.49 | |
| Operating Profit | 0.71 | 0.96 | 1.82 | 1.41 | 1.59 | 2.39 | 4.17 | 3.85 | 3.61 | 4.47 | 5.14 | 5.89 |
| OPM % | 10.86% | 8.78% | 11.42% | 13.01% | 12.41% | 17.59% | 16.76% | 17.88% | 18.24% | 16.37% | 11.44% | 8.37% |
| 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.02 | 0.33 | 0.49 | 0.01 | -0.04 | 0.08 | 0.06 | |
| Interest | 0.01 | 0.01 | 0.07 | 0.24 | 0.20 | 0.23 | 0.10 | 0.24 | 0.27 | 0.21 | 0.62 | 0.65 |
| Depreciation | 0.54 | 0.49 | 0.35 | 0.35 | 0.34 | 0.34 | 0.37 | 0.42 | 0.62 | 1.04 | 1.02 | 0.38 |
| Profit before tax | 0.16 | 0.47 | 1.41 | 0.83 | 1.05 | 1.84 | 4.03 | 3.68 | 2.73 | 3.18 | 3.58 | 4.92 |
| Tax % | 0.00% | 10.64% | 0.71% | 3.61% | 2.86% | 11.41% | 16.38% | 33.97% | 22.71% | 45.28% | 18.99% | 30.89% |
| 0.16 | 0.43 | 1.40 | 0.80 | 1.03 | 1.64 | 3.37 | 2.43 | 2.12 | 1.74 | 2.90 | 3.40 | |
| EPS in Rs | 0.26 | 0.67 | 2.17 | 1.24 | 1.60 | 2.55 | 5.24 | 3.78 | 3.29 | 2.70 | 4.51 | 5.28 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 62.52% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 23% |
| 3 Years: | 53% |
| TTM: | 57% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 0% |
| 3 Years: | 17% |
| TTM: | 17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | -8% |
| 3 Years: | 7% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 13% |
| 3 Years: | 13% |
| Last Year: | 14% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.10 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 |
| Reserves | -0.96 | -0.88 | 0.53 | 1.33 | 2.36 | 3.35 | 6.73 | 9.16 | 11.28 | 13.02 | 15.92 | 19.32 |
| 0.09 | 0.08 | 1.91 | 1.77 | 0.16 | 1.12 | 0.93 | 0.04 | 0.02 | 1.24 | 7.41 | 7.79 | |
| 0.77 | 0.98 | 2.63 | 1.56 | 1.84 | 2.23 | 3.13 | 3.69 | 3.96 | 4.18 | 6.06 | 7.38 | |
| Total Liabilities | 6.00 | 6.62 | 11.51 | 11.10 | 10.80 | 13.14 | 17.23 | 19.33 | 21.70 | 24.88 | 35.83 | 40.93 |
| 3.66 | 3.31 | 3.53 | 3.58 | 3.57 | 3.31 | 3.88 | 5.00 | 6.56 | 5.52 | 4.59 | 4.16 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2.34 | 3.31 | 7.98 | 7.52 | 7.23 | 9.83 | 13.01 | 14.33 | 15.14 | 19.36 | 31.24 | 36.77 | |
| Total Assets | 6.00 | 6.62 | 11.51 | 11.10 | 10.80 | 13.14 | 17.23 | 19.33 | 21.70 | 24.88 | 35.83 | 40.93 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.38 | 0.38 | -0.69 | 0.11 | 2.64 | -0.36 | 4.46 | -0.70 | 2.51 | 2.69 | 0.07 | -2.49 | |
| -0.40 | -0.16 | -1.95 | 0.14 | -0.31 | -0.71 | -2.09 | 0.07 | 0.06 | 0.29 | -5.33 | -2.36 | |
| 0.11 | 0.01 | 2.06 | -0.42 | -1.60 | 0.32 | 0.32 | -1.20 | -0.53 | 1.19 | 5.40 | -0.17 | |
| Net Cash Flow | 0.08 | 0.23 | -0.58 | -0.18 | 0.74 | -0.74 | 2.69 | -1.83 | 2.04 | 4.18 | 0.13 | -5.01 |
| Free Cash Flow | -0.02 | 0.24 | -1.26 | -0.29 | 2.31 | -0.44 | 3.20 | -1.90 | 2.59 | 2.69 | -0.02 | -3.10 |
| CFO/OP | 54% | 40% | -38% | 8% | 166% | -15% | 107% | -18% | 70% | 60% | 1% | -42% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 12.84 | 27.72 | 100.52 | 139.06 | 94.88 | 182.37 | 87.88 | 131.22 | 136.67 | 100.41 | 99.46 | 92.68 |
| Inventory Days | 218.30 | 143.24 | 115.92 | 202.88 | 149.49 | 92.38 | 64.09 | 106.83 | 141.55 | 93.59 | 66.20 | 55.93 |
| Days Payable | 108.28 | 81.70 | 84.18 | 36.13 | 46.29 | 58.58 | 22.10 | 57.67 | 78.93 | 60.94 | 35.55 | 35.90 |
| Cash Conversion Cycle | 122.86 | 89.26 | 132.26 | 305.81 | 198.08 | 216.16 | 129.86 | 180.37 | 199.29 | 133.06 | 130.10 | 112.71 |
| Working Capital Days | 57.48 | 53.10 | 74.88 | 124.92 | 112.83 | 155.78 | 68.66 | 163.09 | 156.77 | 98.27 | 49.00 | 77.53 |
| ROCE % | 3.31% | 8.83% | 20.39% | 11.62% | 13.51% | 20.84% | 33.11% | 26.36% | 17.97% | 17.90% | 16.64% | 17.59% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Ayurvedic Medicines Share of Sale of Products % |
|
||||||||
| Number of Permanent Employees count |
|||||||||
| Ojasvita Share of Sale of Products % |
|||||||||
| Veg Capsules & Cookies Share of Sale of Products % |
|||||||||
| Power Consumption KWH |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10h - Regulation 74(5) certificate for quarter ended 30 June 2026; no securities received for dematerialization or rematerialization.
-
Closure of Trading Window
30 Jun - Trading window closed from July 1, 2026 until 48 hours after Q1 FY2027 results.
-
Incorporation Of A Wholly Owned Subsidiary Company
19 Jun - Source Natural Estates Private Limited incorporated on 18 June 2026 as wholly-owned subsidiary for renewable energy projects.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 May - Newspaper Publication for the Audited Financial Results for the quarter and year ended March 31, 2026
-
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Re-Appointment Of Cost Auditor And Internal Auditor Of The Company For The Financial Year 206-27
28 May - Board reappointed Chiranjeevulu Jeelaga & Co. as Cost Auditor and Ganga Prakash & Co. as Internal Auditor for FY2026-27.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
SNFHSL is in the business of Ayurvedic Medicines and Foods Supplements segments.
The company is expanding its portfolios in green energy vertical and is also focusing on diversification into wastewater and solid waste
management.